Active Pharmaceutical Ingredient (API)
Denosumab
RANKL Inhibitor (Bone Resorption)
A monoclonal antibody used to treat osteoporosis and bone-related complications of cancer. It targets and inhibits RANKL (Receptor Activator of Nuclear factor Kappa $\text{B}$ Ligand), thereby preventing the maturation and activity of osteoclasts (bone-resorbing cells).
Technical Profile
- Reference Code
- DEN437
- CAS Number
- 676472-97-6
- Molecular Weight
- 147,000.00 g/mol
- Chemical Class
- N/A
- Molecular Formula
- N/A
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Denosumab as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| No verified brands found for this salt. | ||||